ZS Genetics, Inc.
ResearchMassachusetts, United States11-50 Employees
ZS Genetics, Inc. operates in the research services sector from Wakefield, Massachusetts. The company focuses on cancer genomics and is developing a sequencing technology intended to read DNA molecules far longer than current short-read methods, with the goal of making cancer mutation analysis more precise and accelerating discovery. Its approach aims to overcome limitations of existing DNA sequencing systems, which typically read only hundreds of base pairs at a time. By enabling access to longer DNA reads, the technology is positioned to reveal disease-related information that short-read approaches may miss. Its target customers are researchers and laboratories engaged in cancer research and genetics, who face bottlenecks in data interpretation and speed-to-insight under current sequencing methods. A notable development is a collaboration with Hitachi High Technologies America established in March 2017 to jointly develop and commercialize the company's sequencing platform.